Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Canada part of a multi-country global rollout Novo Nordisk's Canadian patent expired in January 2026, and generic semaglutide became legal in India on March 23, 2026
[2] Introducing semaglutide into this equation brings a different yet complementary mechanism
This led to its adoption as a popular off-label treatment for obesity
Eden connects patients with licensed providers who prescribe personalized treatment plans using FDA-approved medications related to metabolic health
This multi-layered patent protection is designed to prevent other manufacturers from creating generic versions until the key patents expire
Tirzepatide is administered as a subcutaneous injection
US$ 20.43
US$ 28.08
US$ 20.01
US$ 24.53
US$ 28.20
